Federal Register / Vol. 89, No. 244 / Thursday, December 19, 2024 / Notices 103849 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Center for Advancing 

Translational Sciences; Notice of 

Closed Meetings 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Center for 

Advancing Translational Sciences Special 

Emphasis Panel; Understudied Proteins R03. 

Date: January 2, 2025. 

Time: 3:00 p.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Address: National Center for Advancing 

Translational Sciences, National Institutes of 

Health, 9609 Medical Center Drive, Suite 

1E504, Rockville, MD 20892 (Virtual). 

Contact Person: Carol (Chang-Sook) Kim, 

Ph.D., Scientific Review Administrator, 

Scientific Review Branch Division of 

Extramural Activities, National Center for 

Advancing Translational Sciences, National 

Institutes of Health, 9609 Medical Center 

Drive, Suite 1E504, Bethesda, MD 20892, 

(301) 402–1744, carol.kim@nih.gov. 

Name of Committee: National Center for 

Advancing Translational Sciences Special 

Emphasis Panel; Review of Limited 

Competition CTSA R03 Applications. 

Date: January 29, 2025. 

Time: 11:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Address: National Center for Advancing 

Translational Sciences, National Institutes of 

Health, 9609 Medical Center Drive, Suite 

1E504, Rockville, MD 20892 (Virtual). 

Contact Person: Ming Yan, Ph.D., MD, 

Scientific Review Officer, Scientific Review 

Branch Division of Extramural Activities, 

National Center for Advancing Translational 

Sciences, National Institutes of Health, 9609 

Medical Center Drive, Suite 1E504, Bethesda, 

MD 20892, (301) 451–2853, ming.yan@

nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.859, Pharmacology, 

Physiology, and Biological Chemistry 

Research; 93.350, B—Cooperative 

Agreements; 93.859, Biomedical Research 

and Research Training, National Institutes of 

Health, HHS) 

Dated: December 16, 2024. 

David W. Freeman, 

Supervisory Program Analyst, Office of 

Federal Advisory Committee Policy. 

[FR Doc. 2024–30320 Filed 12–18–24; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Biomedical 

Imaging and Bioengineering; Notice of 

Meeting 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of a 

meeting of the National Advisory 

Council for Biomedical Imaging and 

Bioengineering. 

The meeting will be open to the 

public by videocast. The videocast link 

is https://videocast.nih.gov/ 

watch=55255. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications and/or contract proposals, 

the disclosure of which would 

constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Advisory 

Council for Biomedical Imaging and 

Bioengineering NACBIB, January 2025. 

Date: January 22, 2025. 

Open: 12:00 p.m. to 2:30 p.m. 

Agenda: Report from the Institute Director, 

Council Members and other Institute staff. 

Place: National Institutes of Health, DEM 

II, Suite 200, 6707 Democracy Boulevard, 

Bethesda, MD 20817 (Virtual Meeting). 

Closed: 2:45 p.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications and/or proposals. 

Place: National Institutes of Health, DEM 

II, Suite 200, 6707 Democracy Boulevard, 

Bethesda, MD 20817 Virtual Meeting. 

Contact Person: Anna Taylor, Ph.D., 

Associate Director for Research 

Administration, Office of Research 

Administration, National Institute of 

Biomedical Imaging and Bioengineering, 

6707 Democracy Boulevard, Bethesda, MD 

20892, anna.taylor@nih.gov. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

Information is also available on the 

Institute’s/Center’s home page: https://

www.nibib.nih.gov/about-nibib/advisorycouncil, where an agenda and any additional 

information for the meeting will be posted 

when available. 

Dated: December 13, 2024. 

Victoria E. Townsend, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2024–30079 Filed 12–18–24; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HOMELAND 

SECURITY 

Federal Emergency Management 

Agency 

[Docket ID: FEMA–2024–0026] 

Notice of Availability for Safe Room 

Construction, Supplemental 

Programmatic Environmental 

Assessment 

AGENCY: Federal Emergency 

Management Agency, Department of 

Homeland Security (DHS). 

ACTION: Notice of availability; request 

for comment. 

SUMMARY: The Federal Emergency 

Management Agency (FEMA) has 

prepared a Supplemental Programmatic 

Environmental Assessment (SPEA) to 

reevaluate the analysis provided in the 

2011 Final Programmatic Environmental 

Assessment (PEA) for Safe Room 

Construction and Finding of No 

Significant Impact (FONSI). The SPEA 

includes a reevaluation of the 

environmental analysis and underlying 

assumptions of the 2011 PEA. The 

proposed action includes the 

nationwide construction, retrofit, or 

renovation of safe rooms eligible for 

FEMA grant funding. FEMA has made a 

preliminary determination in the SPEA 

that the FONSI determination is valid 

after incorporating the updated analysis 

and revisions contained in the SPEA. 

DATES: Substantive comments must be 

submitted on or before January 21, 2025 

to be assured consideration. 

ADDRESSES: Interested persons may 

submit comments responsive to this 

notice electronically through the 

Federal eRulemaking Portal at https://

www.regulations.gov. All submissions 

received must include the Agency name 

and Docket ID. Regardless of the method 

used for submitting comments or 

material, all submissions will be posted, 

without change, to the Federal 

eRulemaking Portal at https://

www.regulations.gov, and will include 

any personal information you provide. 


lotter on DSK11XQN23PROD with NOTICES1